Dasatinib is an inhibitor of multiple tyrosine kinases. It is marketed as Sprycel for the treatment of chronic myeloid leukemia (CML). It is also indicated for the treatment of adults with Philadelphia chromosome- positive acute lymphoblastic leukemia.

Related categories 1

RxList: Sprycel (Dasatinib)
Information about the drug includes description, dosage, administration, and treatment indications.
[Davinci Mozilla]
Last update:
April 20, 2008 at 18:37:39 UTC
Health
Home
News
Recreation
Reference
Regional
Science
Shopping
Society
Sports
All Languages
Arts
Business
Computers
Games